Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of CR11559ApublicationCriticalpatent/CR11559A/es
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describe un antagonista del receptor opioide kappa selectivo util para tratar la abstinencia y ansiedad por trastorno de uso de alcohol etilico, y/o depresion, o esquizofrenia como condiciones co-patologicas independientes
CR11559A2008-03-252010-07-07Antagonista del receptor opioide selectivo kappa
CR11559A
(es)
Compuestos derivados de (n,2-difenil)- o (2-fenil-n-piridin)- 2-[(pirimidin-5iloxi)metil]ciclopopanocarboxamida, antagonista del receptor de orexina; composicion farmaceutica; que los comprende; y su uso en transtorno del sueño tal como insomnio. (pct fase nacional)